07/28/22 Health Advisory: Novavax Available to Order

Syringe in vial

Requested actions

  • Be aware, Novavax COVID-19 vaccine is now available to order. Food and Drug Administration (FDA) granted it emergency use authorization (EUA) and Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup approved.
    • EUA covers a 2-dose primary series for people 18 years or older, including those with immune compromise.
    • Booster doses are not currently authorized.
    • Expiration dates shown on the vaccine are not accurate. Check the Novavax website for correct expiration dates for specific lot numbers.
  • Novavax supply is limited. Keep orders to 10 to 100 doses, unless you have high demand.
    • Make sure to order enough vaccine for both doses in the series. We expect to have only this single supply of Novavax. 
  • Be aware, Department of Health and Human Services (HHS) purchased 750,000 courses of bebtelovimab. They allocated the courses to providers across the country. The supply is available for full order through Aug. 15 and partial order through Aug. 22. Bebtelovimab will be available for commercial purchase on Aug. 15.
    • These federally purchased doses are the last available without cost to uninsured patients.
    • Prioritize these doses for uninsured patients.

Vaccine

Testing

Processing times

Labs report varying amounts of time to process COVID-19 tests. To support faster turnaround, we encourage providers to use in-state labs. The table below shows COVID-19 test processing times for in-state private labs.

LABTIME TO PROCESS TESTTESTS PROCESSED DAILY
FidaLab24 hours150
Kaiser24–48 hours3,000
LabCorp24–48 hoursUnknown
Northwest Pathology24–48 hours4,000
Quest24–48 hours700
UW Virology12–72 hours3,800
Atlas Genomic24–48 hours10,000

Therapeutics

HHS allocates monoclonal antibodies and oral antivirals to each state. DOH distributes doses to enrolled providers. Providers must enroll to order therapies in Health Partner Ordering Portal (HPoP) to manage COVID-19 therapies. For help, email mcm@doh.wa.gov.

Additional information

Prevention

Share with patients:

Reporting

Call (509) 725-1001 or fax positive lab results to the confidential fax (509) 725-1014.

Contacting the Health Department

Here’s how you can contact us: Front desk: (509) 725-1001, M–F, 8 a.m.–4:30 p.m. Confidential fax: (509) 725-1014 To report a communicable disease, call the front desk at (509) 725-1001. For after hours reporting of immediately notifiable conditions, call (509) 995-9833 or (509) 951-4882.

Additional resources